Veterinary Medicines

Linco-Spectin solution injectable pour porcs et moutons

Authorised
  • Spectinomycin
  • Lincomycin
Download as PDF

Product identification

Medicine name:
Linco-Spectin solution injectable pour porcs et moutons
Linco-Spectin injektionslösung
Active substance:
  • Spectinomycin
  • Lincomycin
Target species:
  • Sheep
  • Pig
Route of administration:
  • Intramuscular use

Product details

Active substance and strength:
  • Spectinomycin
    100.00
    milligram(s)
    /
    1.00
    millilitre(s)
  • Lincomycin
    50.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Sheep
      • Milk
        no withdrawal period
      • Meat and offal
        15
        day
    • Pig
      • Meat and offal
        12
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01FF52
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Luxembourg
Available in:
  • Luxembourg
Package description:
  • Linco-Spectin 20 ml Vial Solution for injection
  • Linco-Spectin 50 ml Vial Solution for injection
  • Linco-Spectin 100 ml Vial Solution for injection
  • Linco-Spectin 250 ml Vial Solution for injection

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Zoetis Belgium
Marketing authorisation date:
Manufacturing sites for batch release:
  • Bela-Pharm GmbH & Co. KG
  • Zoetis Belgium
Responsible authority:
  • Ministere De La Sante Division De La Pharmacie Et Des Medicaments
Authorisation number:
  • V 087/05/03/0823
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 16/03/2023
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."